CAR T-Cell Therapy for Kidney Cancer Builds on Efficacy Record

Published Date: 11 Nov 2024

Confirmed responses in one-fourth to one-third of patients with refractory disease

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Tafasitamab-Based Combination Boosts PFS in Relapsed/Refractory Follicular Lymphoma

2.

Intractable cancers may respond better to treatment when using new radiation and high-performance computing.

3.

Combo of Approved Agents Active in High-Risk Large B-Cell Lymphoma

4.

A Texas study found that the majority of pancreatic cancer patients do not receive life-saving surgery.

5.

Clinical trial results show low-intensity therapy can achieve positive outcomes for certain pediatric leukemia subtypes


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot